This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40115, first published .
The Effect of Prophylactic Intravenous Amiodarone Administration on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Cardiopulmonary Bypass Surgery: Protocol for a Randomized Double-Blind Clinical Trial

The Effect of Prophylactic Intravenous Amiodarone Administration on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Cardiopulmonary Bypass Surgery: Protocol for a Randomized Double-Blind Clinical Trial

The Effect of Prophylactic Intravenous Amiodarone Administration on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Cardiopulmonary Bypass Surgery: Protocol for a Randomized Double-Blind Clinical Trial

Authors of this article:

Xiaokai Zhou1 Author Orcid Image ;   Zhenfeng Zhang1 Author Orcid Image ;   Chanjuan Gong1 Author Orcid Image ;   Yin Fang1 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Liu S, Wu Z, Su Y, Qiu F. Successful treatment of sepsis-induced cardiomyopathy with 36 hours refractory ventricular fibrillation: A case report. Heliyon 2024;10(15):e35084 View